Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

The financial elements are good but the company seems high valued with a price earnings ratio of 16 times due especially to downgrade of earnings per share estimates, according to analysts polled by Reuters.

Technically the share is testing an important threshold at USD 69.5. Moving averages are well oriented and are supporting the share. The break out of this resistance could open new high scenarios. In this case we suggest long position in order to aim the historic highs of USD 73. The stop loss will be placed below the USD 69 threshold .